Aristotle Capital Boston’s Community Healthcare Trust CHCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.76M | Sell |
425,572
-81,869
| -16% | -$1.38M | 0.42% | 94 |
|
|
2025
Q4 | $8.33M | Sell |
507,441
-53,755
| -10% | -$803K | 0.46% | 88 |
|
|
2025
Q3 | $8.59M | Sell |
561,196
-6,792
| -1% | -$106K | 0.44% | 87 |
|
|
2025
Q2 | $9.45M | Sell |
567,988
-32,149
| -5% | -$530K | 0.48% | 79 |
|
|
2025
Q1 | $10.9M | Sell |
600,137
-104,291
| -15% | -$1.99M | 0.54% | 75 |
|
|
2024
Q4 | $13.5M | Sell |
704,428
-84,119
| -11% | -$1.53M | 0.5% | 78 |
|
|
2024
Q3 | $14.3M | Buy |
788,547
+168,954
| +27% | +$3.45M | 0.47% | 78 |
|
|
2024
Q2 | $14.5M | Buy |
619,593
+5,399
| +0.9% | +$131K | 0.49% | 78 |
|
|
2024
Q1 | $16.3M | Sell |
614,194
-7,110
| -1% | -$187K | 0.5% | 79 |
|
|
2023
Q4 | $16.6M | Buy |
621,304
+13,204
| +2% | +$364K | 0.51% | 81 |
|
|
2023
Q3 | $18.1M | Buy |
608,100
+1,050
| +0.2% | +$35.2K | 0.58% | 72 |
|
|
2023
Q2 | $20M | Buy |
607,050
+7,885
| +1% | +$274K | 0.6% | 67 |
|
|
2023
Q1 | $21.9M | Buy |
599,165
+16,651
| +3% | +$649K | 0.68% | 64 |
|
|
2022
Q4 | $20.9M | Sell |
582,514
-12,110
| -2% | -$413K | 0.66% | 66 |
|
|
2022
Q3 | $19.5M | Sell |
594,624
-28,516
| -5% | -$1.05M | 0.66% | 64 |
|
|
2022
Q2 | $22.6M | Buy |
623,140
+28,443
| +5% | +$1.07M | 0.67% | 61 |
|
|
2022
Q1 | $25.1M | Sell |
594,697
-22,215
| -4% | -$962K | 0.63% | 70 |
|
|
2021
Q4 | $29.2M | Sell |
616,912
-5,201
| -0.8% | -$239K | 0.68% | 67 |
|
|
2021
Q3 | $28.1M | Buy |
622,113
+7,460
| +1% | +$362K | 0.66% | 68 |
|
|
2021
Q2 | $29.2M | Sell |
614,653
-50,615
| -8% | -$2.48M | 0.67% | 67 |
|
|
2021
Q1 | $30.7M | Buy |
665,268
+3,921
| +0.6% | +$182K | 0.68% | 65 |
|
|
2020
Q4 | $31.2M | Sell |
661,347
-28,067
| -4% | -$1.33M | 0.74% | 52 |
|
|
2020
Q3 | $32.2M | Buy |
689,414
+9,197
| +1% | +$421K | 0.93% | 37 |
|
|
2020
Q2 | $27.8M | Buy |
680,217
+76,131
| +13% | +$2.85M | 0.85% | 43 |
|
|
2020
Q1 | $23.1M | Buy |
604,086
+11,482
| +2% | +$499K | 0.99% | 37 |
|
|
2019
Q4 | $25.4M | Sell |
592,604
-110,385
| -16% | -$5.03M | 0.7% | 63 |
|
|
2019
Q3 | $31.3M | Buy |
702,989
+88,811
| +14% | +$3.74M | 0.92% | 44 |
|
|
2019
Q2 | $24.2M | Buy |
614,178
+34,862
| +6% | +$1.3M | 0.76% | 56 |
|
|
2019
Q1 | $20.8M | Buy |
579,316
+160,494
| +38% | +$5.33M | 0.69% | 65 |
|
|
2018
Q4 | $12.1M | Buy |
418,822
+54,391
| +15% | +$1.62M | 0.99% | 45 |
|
|
2018
Q3 | $11.3M | Sell |
364,431
-24,812
| -6% | -$757K | 0.83% | 62 |
|
|
2018
Q2 | $11.6M | Sell |
389,243
-17,858
| -4% | -$479K | 0.92% | 54 |
|
|
2018
Q1 | $10.5M | Buy |
407,101
+97,339
| +31% | +$2.47M | 0.49% | 83 |
|
|
2017
Q4 | $8.7M | Buy |
309,762
+37,811
| +14% | +$1.05M | 0.63% | 73 |
|
|
2017
Q3 | $7.33M | Buy |
+271,951
| New | +$7.01M | 0.66% | 69 |
|
Other funds holding CHCT
VPM
VCM
SFM
KCM
N
Aristotle Capital Boston's CHCT Position: Q1 2026 in Review
Aristotle Capital Boston reduced its Community Healthcare Trust (CHCT) stake by 16% in Q1 2026, selling an estimated $1.38M and leaving 425,572 shares worth $6.76M. The position accounts for 0.42% of the portfolio, ranked #94.
Aristotle Capital Boston first reported a position in CHCT in Q3 2017 and has held it in 35 quarters since. The position peaked at $32.2M in Q3 2020. 162 funds tracked by Wall St. Rank hold CHCT as of Q1 2026.
- Aristotle Capital Boston held 425,572 shares of Community Healthcare Trust worth $6.76M as of Q1 2026.
- Aristotle Capital Boston sold 81,869 Community Healthcare Trust shares in Q1 2026, an estimated $1.38M.
- Community Healthcare Trust made up 0.42% of Aristotle Capital Boston's portfolio in Q1 2026, its #94 holding.
- Aristotle Capital Boston first reported a position in Community Healthcare Trust in Q3 2017 and has held it in 35 quarters since.
- Aristotle Capital Boston's Community Healthcare Trust position peaked at $32.2M in Q3 2020.
- 162 funds tracked by Wall St. Rank held Community Healthcare Trust as of Q1 2026.
Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.